If you haven’t yet, join the MintHealth Telegram channel to hear directly from MintHealth founders and advisors. We love engaging with the community and answering any questions.
In addition to executives and advisors contributing throughout the day, we’ve added a live bi-weekly Q&A session, kicking off this Wednesday, January 17th at 1:00pm PT.
Additional upcoming Q&A ‘s:
Wednesday, January 31st @ 1pm PT
Wednesday, February 14th @ 1pm PT
Wednesday, February 28th @ 1pm PT
Wednesday, March 14th @ 1pm PT
Wednesday, March 28th @ 1pm PT
This week’s chat features MintHealth executives:
Dr. Jean Balgrosky (CIO)
Dr. Balgrosky is a former CIO of large, complex healthcare organizations, including Scripps Health and Holy Cross Health System (now Trinity Health System). With a PhD in Health Policy and Management, Jean serves on the faculty at UCLA Fielding School of Public Health. She is founder of Bootstrap Incubation, LLC, a firm established to invest, mentor and grow life science and information technology start-ups.
Dr. Samir Damani (CEO & Director)
Dr. Damani founded MD Revolution with the purpose of building the gold standard technology
enabled service platform for chronic care management (CCM). Today, MDR is the leading platform in the nation for Medicare’s CCM program and is being leveraged by thousands of patients and providers across the nation. MD Revolution integrates patient generated data, electronic health records, and physician workflow for the purpose of optimizing population health management. He has served in multiple strategic and operational roles, as well as led efforts in raising over $43 million for the founding vision as CEO. Dr. Damani remains highly active as an MD Revolution Board Member. He also serves as a Clinical Instructor in the Department of Family & Preventive Medicine for the UC San Diego Medical School and is a board-certified practicing cardiologist at Scripps Clinic – a top 20 US News and World Report heart care center.
Dr. Damani has also served as a scientific adviser for the prominent journal, Science Translational Medicine, and continues to serve as a reviewer for Nature Genetics, Annals of Internal Medicine, American Journal of Cardiology, and the Journal of the American College of Cardiology. In addition to his medical training, Dr. Damani has a Doctorate in Pharmacy from the University of Georgia and a Masters in Clinical Investigation from the Scripps Research Institute.